Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line

Neurochemical Research

Volumn 42, Issue 10, 2017, Pages 2788-2797

  Kunzler, Alice ^a   Kolling, Eduardo Antônio ^a   da Silva Jr, Jeferson Delgado ^a   Gasparotto, Juciano ^a   de Bittencourt Pasquali, Matheus Augusto ^b   Moreira, José Cláudio Fonseca ^a   Gelain, Daniel Pens ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

Author keywords

Neurodegeneration; Neurotoxicity; Oxidative stress; RAGE; SH SY5Y; Vitamin A

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; RETINOL; TAU PROTEIN; TROLOX C; ANTIOXIDANT;

ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SH-SY5Y CELL LINE; UPREGULATION; VITAMIN SUPPLEMENTATION; CELL LINE; CELL SURVIVAL; DRUG EFFECT; METABOLISM; PHOSPHORYLATION;

ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; HUMANS; NEURONS; PHOSPHORYLATION; TAU PROTEINS; VITAMIN A;

EID: 85019148166     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-017-2292-y     Document Type: Article

References (56)

1. Tafti M, Ghyselinck NB (2007) Functional implication of the vitamin A signaling pathway in the brain. Arch Neurol 64:1706–1711
2. Elliott R (2005) Mechanisms of genomic and non-genomic actions of carotenoids. Biochim Biophys Acta 1740:147–154
3. Goodman M, Bostick RM, Kucuk O, Jones DP (2011) Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med 51:1068–1084
4. Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Oxford University Press, Oxford
5. Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53:4094–4125
6. Berrocal R, Vasquez V, Rao Krs S, Gadad BS, Rao KS (2015) Alpha-synuclein misfolding versus aggregation relevance to Parkinson’s disease: critical assessment and modeling. Mol Neurobiol 51:1417–1431
7. Mondragon-Rodriguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S (2013) Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer’s disease. Oxid Med Cell Longev 2013:940603
8. Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 587:2046–2054
9. Yan SS, Chen D, Yan S, Guo L, Du H, Chen JX (2012) RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer’s disease. Front Biosci 4:240–250
10. Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M, Chang L, Yan LJ, Zhao B (2016) Role of RAGE in Alzheimer’s disease. Cell Mol Neurobiol 36:483–495
11. Ray R, Juranek JK, Rai V (2016) RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neurosci Biobehav Rev 62:48–55
12. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658
13. Goodman GE, Omenn GS, Thornquist MD, Lund B, Metch B, Gylys-Colwell I (1993) The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 2:389–396
14. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr., Valanis B, Williams JH Jr., Barnhart S, Cherniack MG, Brodkin CA, Hammar S (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88:1550–1559
15. The ABC-Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029–1035
16. Mongan NP, Gudas LJ (2007) Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75:853–870
17. Gelain DP, de Bittencourt Pasquali MA, Caregnato FF, Moreira JC (2011) Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation. Toxicology 289:38–44
18. Ross AC, Zolfaghari R, Weisz J (2001) Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids. Curr Opin Gastroenterol 17:184–192
19. de Bittencourt Pasquali MA, Gelain DP, Zeidan-Chulia F, Pires AS, Gasparotto J, Terra SR, Moreira JC (2013) Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells. Cell Signal 25:939–954
20. Gelain DP, Cammarota M, Zanotto-Filho A, de Oliveira RB, Dal-Pizzol F, Izquierdo I, Bevilaqua LR, Moreira JC (2006) Retinol induces the ERK1/2-dependent phosphorylation of CREB through a pathway involving the generation of reactive oxygen species in cultured sertoli cells. Cell Signal 18:1685–1694
21. Owusu SA, Ross AC (2016) Retinoid homeostatic gene expression in liver, lung and kidney: ontogeny and response to vitamin A-retinoic acid (VARA) supplementation from birth to adult age. PLoS ONE 11:e0145924
22. Lengyel JN, Park EY, Brunson AR, Pinali D, Lane MA (2014) Phosphatidylinositol 3-kinase mediates the ability of retinol to decrease colorectal cancer cell invasion. Nutr Cancer 66:1352–1361
23. Teismann P, Sathe K, Bierhaus A, Leng L, Martin HL, Bucala R, Weigle B, Nawroth PP, Schulz JB (2012) Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiol Aging 33:2478–2490
24. Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, Schulte C, Mustafa S, Synofzik M, Vukovic Z, Itohara S, Berg D, Teismann P (2012) S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain 135:3336–3347
25. Le Prell CG, Hughes LF, Miller JM (2007) Free radical scavengers vitamins A, C, and E plus magnesium reduce noise trauma. Free Radic Biol Med 42:1454–1463
26. Fang YZ, Yang S, Wu G (2002) Free radicals, antioxidants, and nutrition. Nutrition 18:872–879
27. Gelain DP, Moreira JC, Bevilaqua LR, Dickson PW, Dunkley PR (2007) Retinol activates tyrosine hydroxylase acutely by increasing the phosphorylation of serine40 and then serine31 in bovine adrenal chromaffin cells. J Neurochem 103:2369–2379
28. Gelain DP, Moreira JC (2008) Evidence of increased reactive species formation by retinol, but not retinoic acid, in PC12 cells. Toxicol Vitro 22:553–558
29. Pasquali MA, Gelain DP, de Oliveira MR, Behr GA, da Motta LL, da Rocha RF, Klamt F, Moreira JC (2009) Vitamin A supplementation for different periods alters oxidative parameters in lungs of rats. J Med Food 12:1375–1380
30. Pasquali MA, Gelain DP, Oliveira MR, Behr GA, Motta LL, Rocha RF, Klamt F, Moreira JC (2009) Vitamin A supplementation induces oxidative stress and decreases the immunocontent of catalase and superoxide dismutase in rat lungs. Exp Lung Res 35:427–438
31. Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA (2011) Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008524.pub3
32. Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA (2011) Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ 343:d5094
33. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155
34. Paraskevas GP, Kapaki E, Petropoulou O, Anagnostouli M, Vagenas V, Papageorgiou C (2003) Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism. J Neurol Sci 215:51–55
35. de Oliveira MR, Oliveira MW, Behr GA, Hoff ML, da Rocha RF, Moreira JC (2009) Evaluation of the effects of vitamin A supplementation on adult rat substantia nigra and striatum redox and bioenergetic states: mitochondrial impairment, increased 3-nitrotyrosine and alpha-synuclein, but decreased D2 receptor contents. Prog Neuro Psychopharmacol Biol Psychiatry 33:353–362
36. Lee HP, Casadesus G, Zhu X, Lee HG, Perry G, Smith MA, Gustaw-Rothenberg K, Lerner A (2009) All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease. Expert Rev Neurother 9:1615–1621
37. Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH (2008) Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer’s disease transgenic mouse model. J Neurosci 28:11622–11634
38. Mondragon-Rodriguez S, Perry G, Luna-Munoz J, Acevedo-Aquino MC, Williams S (2014) Phosphorylation of tau protein at sites Ser(396–404) is one of the earliest events in Alzheimer’s disease and Down syndrome. Neuropathol Appl Neurobiol 40:121–135
39. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer’s disease amyloid beta peptide. Biochim Biophys Acta 1768:1976–1990
40. Maczurek A, Shanmugam K, Munch G (2008) Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer’s disease. Ann N Y Acad Sci 1126:147–151
41. Candela P, Gosselet F, Saint-Pol J, Sevin E, Boucau MC, Boulanger E, Cecchelli R, Fenart L (2010) Apical-to-basolateral transport of amyloid-beta peptides through blood–brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimer’s Dis 22:849–859
42. Valente T, Gella A, Fernandez-Busquets X, Unzeta M, Durany N (2010) Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus. Neurobiol Dis 37:67–76
43. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Gotz J, Eckert A (2012) Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid Redox Signal 16:1456–1466
44. Watamura N, Toba J, Yoshii A, Nikkuni M, Ohshima T (2016) Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer’s disease model mice: involvement of Cdk5 phosphorylation and the effect of ATRA treatment. J Neurosci Res 94:15–26
45. Jamsa A, Hasslund K, Cowburn RF, Backstrom A, Vasange M (2004) The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylation. Biochem Biophys Res Commun 319:993–1000
46. Pugazhenthi S, Qin L, Reddy PH (2016) Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta. doi:10.1016/j.bbadis.2016.04.017
47. Kojro E, Postina R (2009) Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer’s disease. J Alzheimer’s Dis 16:865–878
48. Li XH, Lv BL, Xie JZ, Liu J, Zhou XW, Wang JZ (2012) AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2011.02.003.
49. Barroso E, del Valle J, Porquet D, Vieira Santos AM, Salvado L, Rodriguez-Rodriguez R, Gutierrez P, Anglada-Huguet M, Alberch J, Camins A, Palomer X, Pallas M, Michalik L, Wahli W, Vazquez-Carrera M (2013) Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARbeta/delta-null mice. Biochim Biophys Acta 1832:1241–1248
50. Gao J, Teng J, Liu H, Han X, Chen B, Xie A (2014) Association of RAGE gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population. Neurosci Lett 559:158–162
51. Santoro M, Maetzler W, Stathakos P, Martin HL, Hobert MA, Rattay TW, Gasser T, Forrester JV, Berg D, Tracey KJ, Riedel G, Teismann P (2016) In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson’s disease which can be attenuated by glycyrrhizin. Neurobiol Dis 91:59–68
52. Queisser MA, Kouri FM, Konigshoff M, Wygrecka M, Schubert U, Eickelberg O, Preissner KT (2008) Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 39:337–345
53. Creagh-Brown BC, Quinlan GJ, Evans TW, Burke-Gaffney A (2010) The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med 36:1644–1656
54. Penniston KL, Tanumihardjo SA (2006) The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 83:191–201
55. Etchamendy N, Enderlin V, Marighetto A, Pallet V, Higueret P, Jaffard R (2003) Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res 145:37–49
56. Schnorr CE, da Silva Morrone M, Simoes-Pires A, da Rocha RF, Behr GA, Moreira JC (2011) Vitamin A supplementation in rats under pregnancy and nursing induces behavioral changes and oxidative stress upon striatum and hippocampus of dams and their offspring. Brain Res 1369:60–73